PTEN and endometrium adenocarcinoma: For instance, depending on the Cre recombinase expressing mice used for conditional ablation of Pten, some models develop invasive endometrial adenocarcinomas,[20] in situ endometrial adenocarcinomas[22] or endometrial hyperplasia.[29] Disparities have been also reported for p53 mouse models.